SCHEMBL225786

SCHEMBL225786

CC(=O)c1cc(O)c(O)cc1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.58
HPGD P15428 5/20 0.53
CYP3A4 P08684 5/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
ALDH1A1 P00352 3/20 0.52
ALOX15 P16050 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
TSHR P16473 1/20 0.52
RECQL P46063 1/20 0.52
HSD17B10 Q99714 1/20 0.52
ALOX12 P18054 1/20 0.52
KDM4E B2RXH2 2/20 0.48
MAPT P10636 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30350322 1.00 HTT (0.58) HTTHPGDCYP3A4MEN1KMT2A
SCHEMBL8472608 0.94 HTT (0.62) HTTHPGDCYP3A4MEN1KMT2A
SCHEMBL1258995 0.92 HTT (0.60) HTTHPGDCYP3A4MEN1KMT2A
SCHEMBL15835586 0.84 HTT (0.54) HTTHPGDCYP3A4MEN1KMT2A
SCHEMBL25343188 0.82 HTT (0.52) HTTHPGDCYP3A4MEN1KMT2A
SCHEMBL3459807 0.82 HTT (0.52) HTTHPGDCYP3A4MEN1KMT2A
SCHEMBL29457564 0.82 HTT (0.52) HTTHPGDCYP3A4MEN1KMT2A
SCHEMBL30007557 0.82 HTT (0.52) HTTHPGDCYP3A4MEN1KMT2A
SCHEMBL4167959 0.82 HTT (0.52) HTTHPGDCYP3A4MEN1KMT2A
SCHEMBL3656900 0.82 HTT (0.52) HTTHPGDCYP3A4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 343 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114867708-B Method for synthesizing benzyl ether from polyhydroxy phenol 泉州海创医药科技有限公司 2024-07-23 CN claimed
US-20230167545-A1 STABILIZATION OF CARBON DEPOSITION PRECURSORS LIKE C2H2 LAM RESEARCH CORPORATION 2023-06-01 US claimed
EP-4118064-A1 <SUP2/>? <SUB2/>?2?STABILIZATION OF CARBON DEPOSITION PRECURSORS LIKE CH <NS1:SUB>2</NS1:SUB> Lam Research Corporation (US) 2023-01-18 EP claimed
CN-115551822-A Carbon deposition precursors such as C 2 H 2 Is stabilized by 朗姆研究公司 2022-12-30 CN claimed
CN-114867708-A Method for synthesizing benzyl ether from polyhydroxyphenol 泉州海创医药科技有限公司 2022-08-05 CN claimed
WO-2022117071-A1 METHOD FOR SYNTHESIZING BENZYL ETHER FROM POLYHYDRIC PHENOL 福建海创医药科技有限公司 2022-06-09 WO claimed
WO-2021183922-A1 STABILIZATION OF CARBON DEPOSITION PRECURSORS LIKE C2H2 LAM RESEARCH CORPORATION (US) 2021-09-16 WO claimed
CN-109806247-A New use of paeonol and in vivo metabolite thereof 天津中医药大学 2019-05-28 CN claimed
CN-103130760-B Novel targeting antineoplastic drug and manufacture method thereof and application thereof DALIAN CHEMICAL PHYSICS INST 2015-06-17 CN claimed
US-20150090252-A1 APPARATUS AND PROCESS FOR PASTEURIZATION OF SAP AND PRODUCT THEREOF FEDERATION DES PRODUCTEURS ACERICOLES DU QUEBEC (CA) 2015-04-02 US claimed
WO-2012055010-A1 MAPLE TREE-DERIVED PRODUCTS AND USES THEREOF FÉDÉRATION DES PRODUCTEURS ACÉRICOLES DU QUÉBEC (CA) 2012-05-03 WO claimed
WO-2012021981-A1 NOVEL PHYTOCHEMICALS FROM EXTRACTS OF MAPLE SYRUPS AND MAPLE TREES AND USES THEREOF FÉDÉRATION DES PRODUCTEURS ACÉRICOLES DU QUÉBEC (CA) 2012-02-23 WO claimed
US-20080255228-A1 Ascorbic Acid Complexes for Skin Care Including Treatment of Dark Skin & Wrinkles BIODERM RESEARCH (US) 2008-10-16 US claimed
US-20080254130-A1 Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction BIODERM RESEARCH (US) 2008-10-16 US claimed
US-7427690-B2 Multifunction “crown complexes” from amino acids and peptides for skin and hair restoration BIODERM RESEARCH (US) 2008-09-23 US claimed
US-20070099886-A1 Multifunction \"Crown Complexes\" from Amino Acids and Peptides for Skin and Hair Restoration BIODERM RESEARCH (US) 2007-05-03 US claimed
US-20060269494-A1 New Ubiquitin-Proteasome Regulating Compounds and Their Application in Cosmetic and Pharmaceutical Formulations GUPTA SHYAM K 2006-11-30 US claimed
US-20060110415-A1 Topical Delivery System for Cosmetic and Pharmaceutical Agents BIODERM RESEARCH (US) 2006-05-25 US claimed
US-20060074108-A1 Matrix metalloprotease (MMP) inhibitors and their application in cosmetic and pharmaceutical composition BIODERM RESEARCH (US) 2006-04-06 US claimed
US-20050271608-A1 Skin whitening compositions based on hydroxyaryl alkyl ketones and their isosteric derivatives GUPTA SHYAM K 2005-12-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080254130-A1 Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction PSMB1, PLOD3, CUTA HTT 2153/4885HPGD 1094/4885CYP3A4 3624/4885
US-20080255228-A1 Ascorbic Acid Complexes for Skin Care Including Treatment of Dark Skin & Wrinkles PROC, COL1A1, CUTA HTT 2376/4885HPGD 725/4885CYP3A4 1140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.